The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Vaccine for Influenza Market Research Report 2025
Synopsis
The global Vaccine for Influenza market was valued at US$ 7829.8 million in 2023 and is anticipated to reach US$ 11790 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.
This report aims to provide a comprehensive presentation of the global market for Vaccine for Influenza, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine for Influenza.
Report Scope
The Vaccine for Influenza market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine for Influenza market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine for Influenza manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Application
6 Months to 3 Years
> 3 Years
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vaccine for Influenza manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vaccine for Influenza in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Vaccine for Influenza market was valued at US$ 7829.8 million in 2023 and is anticipated to reach US$ 11790 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.
This report aims to provide a comprehensive presentation of the global market for Vaccine for Influenza, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine for Influenza.
Report Scope
The Vaccine for Influenza market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine for Influenza market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine for Influenza manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Application
6 Months to 3 Years
> 3 Years
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vaccine for Influenza manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vaccine for Influenza in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Vaccine for Influenza Market Overview
1.1 Product Overview and Scope of Vaccine for Influenza
1.2 Vaccine for Influenza Segment by Type
1.2.1 Global Vaccine for Influenza Market Value Comparison by Type (2024-2030)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Vaccine for Influenza Segment by Application
1.3.1 Global Vaccine for Influenza Market Value by Application: (2024-2030)
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Global Vaccine for Influenza Market Size Estimates and Forecasts
1.4.1 Global Vaccine for Influenza Revenue 2019-2030
1.4.2 Global Vaccine for Influenza Sales 2019-2030
1.4.3 Global Vaccine for Influenza Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Vaccine for Influenza Market Competition by Manufacturers
2.1 Global Vaccine for Influenza Sales Market Share by Manufacturers (2019-2024)
2.2 Global Vaccine for Influenza Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Vaccine for Influenza Average Price by Manufacturers (2019-2024)
2.4 Global Vaccine for Influenza Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vaccine for Influenza, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccine for Influenza, Product Type & Application
2.7 Vaccine for Influenza Market Competitive Situation and Trends
2.7.1 Vaccine for Influenza Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vaccine for Influenza Players Market Share by Revenue
2.7.3 Global Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vaccine for Influenza Retrospective Market Scenario by Region
3.1 Global Vaccine for Influenza Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Vaccine for Influenza Global Vaccine for Influenza Sales by Region: 2019-2030
3.2.1 Global Vaccine for Influenza Sales by Region: 2019-2024
3.2.2 Global Vaccine for Influenza Sales by Region: 2025-2030
3.3 Global Vaccine for Influenza Global Vaccine for Influenza Revenue by Region: 2019-2030
3.3.1 Global Vaccine for Influenza Revenue by Region: 2019-2024
3.3.2 Global Vaccine for Influenza Revenue by Region: 2025-2030
3.4 North America Vaccine for Influenza Market Facts & Figures by Country
3.4.1 North America Vaccine for Influenza Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Vaccine for Influenza Sales by Country (2019-2030)
3.4.3 North America Vaccine for Influenza Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vaccine for Influenza Market Facts & Figures by Country
3.5.1 Europe Vaccine for Influenza Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Vaccine for Influenza Sales by Country (2019-2030)
3.5.3 Europe Vaccine for Influenza Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccine for Influenza Market Facts & Figures by Country
3.6.1 Asia Pacific Vaccine for Influenza Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Vaccine for Influenza Sales by Country (2019-2030)
3.6.3 Asia Pacific Vaccine for Influenza Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Vaccine for Influenza Market Facts & Figures by Country
3.7.1 Latin America Vaccine for Influenza Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Vaccine for Influenza Sales by Country (2019-2030)
3.7.3 Latin America Vaccine for Influenza Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccine for Influenza Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccine for Influenza Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Vaccine for Influenza Sales by Country (2019-2030)
3.8.3 Middle East and Africa Vaccine for Influenza Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaccine for Influenza Sales by Type (2019-2030)
4.1.1 Global Vaccine for Influenza Sales by Type (2019-2024)
4.1.2 Global Vaccine for Influenza Sales by Type (2025-2030)
4.1.3 Global Vaccine for Influenza Sales Market Share by Type (2019-2030)
4.2 Global Vaccine for Influenza Revenue by Type (2019-2030)
4.2.1 Global Vaccine for Influenza Revenue by Type (2019-2024)
4.2.2 Global Vaccine for Influenza Revenue by Type (2025-2030)
4.2.3 Global Vaccine for Influenza Revenue Market Share by Type (2019-2030)
4.3 Global Vaccine for Influenza Price by Type (2019-2030)
5 Segment by Application
5.1 Global Vaccine for Influenza Sales by Application (2019-2030)
5.1.1 Global Vaccine for Influenza Sales by Application (2019-2024)
5.1.2 Global Vaccine for Influenza Sales by Application (2025-2030)
5.1.3 Global Vaccine for Influenza Sales Market Share by Application (2019-2030)
5.2 Global Vaccine for Influenza Revenue by Application (2019-2030)
5.2.1 Global Vaccine for Influenza Revenue by Application (2019-2024)
5.2.2 Global Vaccine for Influenza Revenue by Application (2025-2030)
5.2.3 Global Vaccine for Influenza Revenue Market Share by Application (2019-2030)
5.3 Global Vaccine for Influenza Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Vaccine for Influenza Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Vaccine for Influenza Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Vaccine for Influenza Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Vaccine for Influenza Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Vaccine for Influenza Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GSK Vaccine for Influenza Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Corporation Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Vaccine for Influenza Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Viatris Vaccine for Influenza Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Vaccine for Influenza Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AstraZeneca Vaccine for Influenza Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Vaccine for Influenza Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hualan Bio Vaccine for Influenza Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Changchun Institute of Biological
6.6.1 Changchun Institute of Biological Corporation Information
6.6.2 Changchun Institute of Biological Description and Business Overview
6.6.3 Changchun Institute of Biological Vaccine for Influenza Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Changchun Institute of Biological Vaccine for Influenza Product Portfolio
6.7.5 Changchun Institute of Biological Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Corporation Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Vaccine for Influenza Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sinovac Vaccine for Influenza Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 BCHT
6.9.1 BCHT Corporation Information
6.9.2 BCHT Description and Business Overview
6.9.3 BCHT Vaccine for Influenza Sales, Revenue and Gross Margin (2019-2024)
6.9.4 BCHT Vaccine for Influenza Product Portfolio
6.9.5 BCHT Recent Developments/Updates
6.10 Jiangsu GDK
6.10.1 Jiangsu GDK Corporation Information
6.10.2 Jiangsu GDK Description and Business Overview
6.10.3 Jiangsu GDK Vaccine for Influenza Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jiangsu GDK Vaccine for Influenza Product Portfolio
6.10.5 Jiangsu GDK Recent Developments/Updates
6.11 KM Biologics
6.11.1 KM Biologics Corporation Information
6.11.2 KM Biologics Vaccine for Influenza Description and Business Overview
6.11.3 KM Biologics Vaccine for Influenza Sales, Revenue and Gross Margin (2019-2024)
6.11.4 KM Biologics Vaccine for Influenza Product Portfolio
6.11.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccine for Influenza Industry Chain Analysis
7.2 Vaccine for Influenza Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccine for Influenza Production Mode & Process
7.4 Vaccine for Influenza Sales and Marketing
7.4.1 Vaccine for Influenza Sales Channels
7.4.2 Vaccine for Influenza Distributors
7.5 Vaccine for Influenza Customers
8 Vaccine for Influenza Market Dynamics
8.1 Vaccine for Influenza Industry Trends
8.2 Vaccine for Influenza Market Drivers
8.3 Vaccine for Influenza Market Challenges
8.4 Vaccine for Influenza Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
